Marshall Wace, LLP Electro Core, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $95,447 - $215,640	-353,509 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.5 - $0.88 $67,873 - $119,456	-135,746 Reduced 27.75%	353,509 $206,000
Q4 2021 Feb 14, 2022	BUY	$0.58 - $1.09 $16,036 - $30,137	27,649 Added 5.99%	489,255 $283,000
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $227,088 - $288,133	244,181 Added 112.31%	461,606 $522,000
Q2 2021 Aug 13, 2021	SELL	$1.19 - $2.06 $86,073 - $149,001	-72,331 Reduced 24.96%	217,425 $259,000

Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $469,404 - $883,755	289,756 New	289,756 $597,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $455M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.